Valued at $2,010.2 million in 2019, the global antimicrobial additives market is predicted to attain a valuation of $3,786.8 million by 2030, demonstrating a CAGR of 7.5% during 2020-2030. The market is being mainly driven by the rapid growth of the healthcare industry, on account of the increasing incidence of chronic diseases, growing geriatric population, and improving healthcare facilities, especially in the developing nations and the surging awareness of infectious diseases across the world.




Between the inorganic and organic categories under the type segmentation of the antimicrobial additives market, the inorganic division is predicted to demonstrate faster growth in the market in the future years. This is ascribed to the fact that the inorganic additives have several favorable chemical characteristics and are non-toxic, unlike the organic variants.


Get a sample copy of this report:
https://www.psmarketresearch.com/market-analysis/antimicrobial-additives-market/report-sample



In the coming years, the healthcare category, under the end-use segmentation of the antimicrobial additives market, is predicted to dominate the market, on account of the rising prevalence of different types of hospital-acquired infections (HAI) across the globe. As per the research paper published on Antimicrobial strategies for polymeric hygienic surfaces in healthcare, 0.8 million and 4 million people suffer from HAIs each year in North America and Europe respectively. The incidence of these infections is even higher in the emerging economies, due to the poor hygiene standards in those countries. Thus, with the increasing public awareness about hygiene and HAIs, the usage of antimicrobial additives in medical devices and healthcare products would increase in the upcoming years.


Geographically, the antimicrobial additives market registered the highest growth in North America during the last few years, mainly because of the high prevalence of HAIs in the region. Additionally, the excessive consumption of antibiotics has caused high bio-resistance in a majority of the population, thereby increasing the difficulty of tackling the problem of the resistant strains of pathogens in the region. Furthermore, antimicrobial additives-based products selling companies charge high prices for their products on account of the high spending power of people in the North American countries.